D.J. St. Germain’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$198K Hold
1,170
0.01% 299
2025
Q4
$197K Hold
1,170
0.01% 304
2025
Q3
$169K Hold
1,170
0.01% 324
2025
Q2
$148K Hold
1,170
0.01% 333
2025
Q1
$150K Hold
1,170
0.01% 290
2024
Q4
$155K Sell
1,170
-15
-1% -$2.11K 0.01% 308
2024
Q3
$173K Hold
1,185
0.01% 282
2024
Q2
$163K Hold
1,185
0.01% 284
2024
Q1
$163K Sell
1,185
-150
-11% -$20.5K 0.01% 281
2023
Q4
$181K Hold
1,335
0.01% 269
2023
Q3
$163K Buy
1,335
+165
+14% +$21K 0.01% 259
2023
Q2
$149K Buy
+1,170
New +$152K 0.01% 264
2021
Q1
Sell
-1,695
Closed -$257K 232
2020
Q4
$257K Hold
1,695
0.02% 208
2020
Q3
$230K Sell
1,695
-597
-26% -$81K 0.02% 198
2020
Q2
$313K Hold
2,292
0.03% 174
2020
Q1
$247K Hold
2,292
0.02% 189
2019
Q4
$276K Sell
2,292
-60
-3% -$6.69K 0.02% 192
2019
Q3
$234K Hold
2,352
0.03% 173
2019
Q2
$257K Buy
+2,352
New +$250K 0.03% 165
2015
Q2
Sell
-2,145
Closed -$246K 106
2015
Q1
$246K Hold
2,145
0.04% 93
2014
Q4
$217K Sell
2,145
-225
-9% -$21.9K 0.03% 102
2014
Q3
$216K Buy
+2,370
New +$208K 0.03% 99
2014
Q1
Sell
-118,452
Closed -$8.96M 105
2013
Q4
$8.96M Sell
118,452
-3,207
-3% -$228K 1.31% 34
2013
Q3
$8.5M Sell
121,659
-29,439
-19% -$1.93M 1.37% 33
2013
Q2
$8.76M Buy
+151,098
New +$8.73M 1.45% 34

Other funds holding IBB

D.J. St. Germain's IBB Position: Q1 2026 in Review

D.J. St. Germain held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 1,170 shares worth $198K. The position accounts for 0.01% of the portfolio, ranked #299.

D.J. St. Germain first reported a position in IBB in Q2 2013 and has held it in 25 quarters since. The position peaked at $8.96M in Q4 2013. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • D.J. St. Germain held 1,170 shares of iShares Biotechnology ETF worth $198K as of Q1 2026.
  • D.J. St. Germain left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up 0.01% of D.J. St. Germain's portfolio in Q1 2026, its #299 holding.
  • D.J. St. Germain first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 25 quarters since.
  • D.J. St. Germain's iShares Biotechnology ETF position peaked at $8.96M in Q4 2013.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on D.J. St. Germain's 13F filing for Q1 2026, filed 13 Apr 2026.